Since its establishment in 1994, Beijing Bokangjian Gene Technology Co., Ltd. has been committed to innovation and development in the biomedical field. As a key strategic component of Hong Kong Unik Bio Technology Group (0690.HK), the company has grown into a comprehensive biopharmaceutical enterprise integrating R&D, production, and commercialization, and has obtained important qualifications such as High-Tech Enterprise, Beijing Specialized and Sophisticated Enterprise, and Foreign-funded R&D Center.
In terms of manufacturing, the company has established a modern production base compliant with GMP standards, equipped with advanced facilities including fully automated oral tablet production lines and B+S Karts funnel filling systems. Leveraging its solid industrialization capabilities, the company's core products Pinapu, Bushutai, and Bugutai achieved sales exceeding 300 million RMB in 2025, laying a strong foundation to reach the 2 billion RMB sales target by 2029.
The company consistently prioritizes innovative R&D as a core driver, with annual R&D investment continuously exceeding 15% of operating revenue. Among its products, the blockbuster innovative drug "Bugutai®", as the first domestic anti-osteoporosis biologic with a clear bone formation-promoting effect, achieved sales of 60 million RMB in its first year on the market, demonstrating significant clinical value and market competitiveness.
Based on steady development in the domestic market, the company is actively expanding its global footprint. After focusing on emerging markets such as the Middle East and Southeast Asia in 2024, in 2025 the company will fully initiate market access procedures in regulated markets like the United States and the European Union, and plans to further expand to Brazil, Malaysia, and other countries, accelerating the construction of a global commercial network.
Looking ahead, the company will continue to strengthen its peptide innovation platform and technological development, focusing on cutting-edge fields such as oral delivery systems and microneedle formulations. Following its successful entry into the medical aesthetics market with the first medical aesthetics product "Jiyantai", the company is conducting strategic collaborations with top research institutions in Singapore, the United States, and other regions to jointly advance the development and industrialization of innovative therapies, aspiring to become a leading enterprise in the biopharmaceutical field.
Employee Basic Benefits
Free accommodation + working lunch + subsidies + full attendance bonus + year-end bonus + social insurance + housing fund + paid training + team building + physical examination + annual leave + welfare leave + birthday card + holiday benefits + travel + CEO travel award + outstanding employee award + ten-year service award and various activities. The company provides broad development space for every employee.
The company can provide accommodation and lunch.
Company Working Hours
8:00-12:00, 13:00-17:00, with weekends off.
Enjoy paid annual leave and national statutory holidays, along with corresponding rank-specific leave and other welfare leaves.
What does Beijing Bokangjian Gene Technology Co., Ltd. require? Who is Beijing Bokangjian Gene Technology Co., Ltd. hiring? recruitment: 销售类占比最多占39.8%，其次是经营管理类占20.3%. What education can get in at ? 本科占比最多占50.4%，其次是大专占37.4%. High education required at ? 硕士占6.5%. Work experience required at ? 1-3年占比最多占45.5%，其次是5-10年占23.6%. Where are the job locations at ? 北京占比最多占61.8%，其次是西安占6.5%. Based on job postings from the past year, for reference only.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
